Polymorphism analysis of estrogen receptor β Gene RsaI and AluI in girls with idiopathic central precocious puberty: investigating the relationship and implications for early risk prediction - Report - MDSpire
Advertisement
Polymorphism analysis of estrogen receptor β Gene RsaI and AluI in girls with idiopathic central precocious puberty: investigating the relationship and implications for early risk prediction
Genetic Variants of Estrogen Receptor β Gene in Girls with ICPP
Overview
This study investigates the association between ERβ gene polymorphisms RsaI and AluI and the risk of idiopathic central precocious puberty (ICPP) in girls. The findings suggest that the RsaI polymorphism is significantly associated with ICPP risk, while the AluI variant shows no significant association.
Background
Idiopathic central precocious puberty (ICPP) is characterized by the early onset of secondary sexual characteristics, with its etiology remaining largely unclear. Genetic polymorphisms, particularly in the estrogen receptor β (ERβ) gene, may influence the development of ICPP by affecting estrogen signaling pathways. Understanding these associations could aid in early risk assessment and management of ICPP.
Data Highlights
Polymorphism
ICPP Group
Control Group
P-value
RsaI Genotype Distribution
Significant differences (χ2 = 5.96)
–
P = 0.04
R Allele Frequency
41.50%
30.00%
P = 0.03
AluI Genotype Distribution
No significant differences
–
P > 0.05
Haplotype Distribution
Rraa more frequent in ICPP (39%)
31%
P = 0.02
Key Findings
The RsaI polymorphism is significantly associated with ICPP risk (OR = 1.58, P < 0.05).
No significant association was found for the AluI polymorphism in ICPP.
Haplotype analysis revealed a significant difference in haplotype distribution between ICPP and control groups.
The Rraa haplotype was more prevalent in the ICPP group compared to controls.
Genotyping of ERβ RsaI may aid in early risk assessment for ICPP.
Clinical Implications
The identification of the RsaI polymorphism as a risk factor for ICPP suggests that genetic testing could be considered in clinical assessments of girls at risk for early puberty. This may facilitate individualized management strategies and early intervention.
Conclusion
The study highlights the potential role of the ERβ RsaI polymorphism in the risk of ICPP, suggesting that further research is warranted to validate these findings and explore their clinical applications.
Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.